Cargando…
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
BACKGROUND: Fluoroquinolone resistant E. coli isolates, that are also resistant to other classes of antibiotics, is a significant challenge to antibiotic treatment and infection control policies. In Central Greece a significant increase of ciprofloxacin-resistant Escherichia coli has occurred during...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548683/ https://www.ncbi.nlm.nih.gov/pubmed/23259844 http://dx.doi.org/10.1186/1471-2334-12-371 |
_version_ | 1782256345985056768 |
---|---|
author | Mavroidi, Angeliki Miriagou, Vivi Liakopoulos, Apostolos Tzelepi, Εva Stefos, Angelos Dalekos, George N Petinaki, Efthymia |
author_facet | Mavroidi, Angeliki Miriagou, Vivi Liakopoulos, Apostolos Tzelepi, Εva Stefos, Angelos Dalekos, George N Petinaki, Efthymia |
author_sort | Mavroidi, Angeliki |
collection | PubMed |
description | BACKGROUND: Fluoroquinolone resistant E. coli isolates, that are also resistant to other classes of antibiotics, is a significant challenge to antibiotic treatment and infection control policies. In Central Greece a significant increase of ciprofloxacin-resistant Escherichia coli has occurred during 2011, indicating the need for further analysis. METHODS: A total of 106 ciprofloxacin-resistant out of 505 E. coli isolates consecutively collected during an eight months period in a tertiary Greek hospital of Central Greece were studied. Antimicrobial susceptibility patterns and mechanisms of resistance to quinolones were assessed, whereas selected isolates were further characterized by multilocus sequence typing and β-lactamase content. RESULTS: Sequence analysis of the quinolone-resistance determining region of the gyrA and parC genes has revealed that 63% of the ciprofloxacin-resistant E. coli harbored a distinct amino acid substitution pattern (GyrA:S83L + D87N; ParC:S80I + E84V), while 34% and 3% carried the patterns GyrA:S83L + D87N; ParC:S80I and GyrA:S83L + D87N; ParC:S80I + E84G respectively. The aac (6’)-1b-cr plasmid-mediated quinolone resistance determinant was also detected; none of the isolates was found to carry the qnrA, qnrB and qnrS. Genotyping of a subset of 35 selected ciprofloxacin-resistant E. coli by multilocus sequence typing has revealed the presence of nine sequence types; ST131 and ST410 were the most prevalent and were exclusively correlated with hospital and health care associated infections, while strains belonging to STs 393, 361 and 162 were associated with community acquired infections. The GyrA:S83L + D87N; ParC:S80I + E84V substitution pattern was found exclusively among ST131 ciprofloxacin-resistant E. coli. Extended-spectrum β-lactamase-positive ST131 ciprofloxacin-resistant isolates produced CTX-M-type enzymes; eight the CTX-M-15 and one the CTX-M-3 variant. CTX-M-1 like and KPC-2 enzymes were detected in five and four ST410 ciprofloxacin-resistant E. coli isolates, respectively. CONCLUSIONS: Our findings suggest that, ST131 and ST410 predominate in the ciprofloxacin resistant E. coli population. |
format | Online Article Text |
id | pubmed-3548683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35486832013-02-04 Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification Mavroidi, Angeliki Miriagou, Vivi Liakopoulos, Apostolos Tzelepi, Εva Stefos, Angelos Dalekos, George N Petinaki, Efthymia BMC Infect Dis Research Article BACKGROUND: Fluoroquinolone resistant E. coli isolates, that are also resistant to other classes of antibiotics, is a significant challenge to antibiotic treatment and infection control policies. In Central Greece a significant increase of ciprofloxacin-resistant Escherichia coli has occurred during 2011, indicating the need for further analysis. METHODS: A total of 106 ciprofloxacin-resistant out of 505 E. coli isolates consecutively collected during an eight months period in a tertiary Greek hospital of Central Greece were studied. Antimicrobial susceptibility patterns and mechanisms of resistance to quinolones were assessed, whereas selected isolates were further characterized by multilocus sequence typing and β-lactamase content. RESULTS: Sequence analysis of the quinolone-resistance determining region of the gyrA and parC genes has revealed that 63% of the ciprofloxacin-resistant E. coli harbored a distinct amino acid substitution pattern (GyrA:S83L + D87N; ParC:S80I + E84V), while 34% and 3% carried the patterns GyrA:S83L + D87N; ParC:S80I and GyrA:S83L + D87N; ParC:S80I + E84G respectively. The aac (6’)-1b-cr plasmid-mediated quinolone resistance determinant was also detected; none of the isolates was found to carry the qnrA, qnrB and qnrS. Genotyping of a subset of 35 selected ciprofloxacin-resistant E. coli by multilocus sequence typing has revealed the presence of nine sequence types; ST131 and ST410 were the most prevalent and were exclusively correlated with hospital and health care associated infections, while strains belonging to STs 393, 361 and 162 were associated with community acquired infections. The GyrA:S83L + D87N; ParC:S80I + E84V substitution pattern was found exclusively among ST131 ciprofloxacin-resistant E. coli. Extended-spectrum β-lactamase-positive ST131 ciprofloxacin-resistant isolates produced CTX-M-type enzymes; eight the CTX-M-15 and one the CTX-M-3 variant. CTX-M-1 like and KPC-2 enzymes were detected in five and four ST410 ciprofloxacin-resistant E. coli isolates, respectively. CONCLUSIONS: Our findings suggest that, ST131 and ST410 predominate in the ciprofloxacin resistant E. coli population. BioMed Central 2012-12-23 /pmc/articles/PMC3548683/ /pubmed/23259844 http://dx.doi.org/10.1186/1471-2334-12-371 Text en Copyright ©2012 Mavroidi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mavroidi, Angeliki Miriagou, Vivi Liakopoulos, Apostolos Tzelepi, Εva Stefos, Angelos Dalekos, George N Petinaki, Efthymia Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
title | Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
title_full | Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
title_fullStr | Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
title_full_unstemmed | Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
title_short | Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification |
title_sort | ciprofloxacin-resistant escherichia coli in central greece: mechanisms of resistance and molecular identification |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548683/ https://www.ncbi.nlm.nih.gov/pubmed/23259844 http://dx.doi.org/10.1186/1471-2334-12-371 |
work_keys_str_mv | AT mavroidiangeliki ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification AT miriagouvivi ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification AT liakopoulosapostolos ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification AT tzelepieva ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification AT stefosangelos ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification AT dalekosgeorgen ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification AT petinakiefthymia ciprofloxacinresistantescherichiacoliincentralgreecemechanismsofresistanceandmolecularidentification |